收藏切换
The omics perspective on heart failure research
收藏切换
PDF
Jin-yue ZHANG, Qi-feng LIU, Liu YANG, Xue-qi LÜ, Ying-hong WANG*
Acta Pharmaceutica Sinica | 2020, 55(5) : 832 - 842
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(5): 832-842
Reviews
The omics perspective on heart failure research
Full
Jin-yue ZHANG, Qi-feng LIU, Liu YANG, Xue-qi LÜ, Ying-hong WANG*
Affiliations
  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2020-05-12 doi: 10.16438/j.0513-4870.2020-0251
Outline
收藏切换

Heart failure is the end stage of many cardiovascular diseases. It seriously affects the safety and quality of life of nearly 40 million people worldwide. At present, the clinical and pathophysiological characteristics of some types of heart failure are unknown, and there is no effective diagnosis and treatment. In recent years, genomics, transcriptomics, epigenomics, proteomics, metabolomics and other omics technologies have been widely used in disease research, providing new opportunities for the prevention, diagnosis and treatment of diseases. These strategies have also brought hope for the reduction in heart failure mortality. Based on the current status of clinical treatment of heart failure, this article reviews the roles and potential applications of these various omics technologies and their opportunities in the study of the pathogenesis of heart failure, clinical diagnosis and treatment, and related drug pharmacodynamics and mechanism of action.

heart failure  /  biomarker  /  omics analysis technique  /  multi-omics analysis  /  heart failure therapy
Jin-yue ZHANG, Qi-feng LIU, Liu YANG, Xue-qi LÜ, Ying-hong WANG. The omics perspective on heart failure research[J]. Acta Pharmaceutica Sinica, 2020 , 55 (5) : 832 -842 . DOI: 10.16438/j.0513-4870.2020-0251
Year 2020 volume 55 Issue 5
PDF
109
38
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0251
  • Receive Date:2020-03-05
  • Online Date:2026-01-21
  • Published:2020-05-12
Article Data
Affiliations
History
  • Received:2020-03-05
  • Revised:2020-04-08
Funding
Affiliations
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0251
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT